)
APT Medical (688617) investor relations material
APT Medical Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Revenue for H1 2026 reached ¥1.53 billion, up 25.75% year-over-year, with net profit attributable to shareholders at ¥537 million, up 26.38%.
Core business segments—electrophysiology and vascular intervention—drove growth, with significant market share gains domestically and internationally.
R&D investment remained robust at ¥197 million, representing 12.89% of revenue.
The company continued to expand its product portfolio, launch new products, and strengthen its competitive position.
Financial highlights
Operating income: ¥1.53 billion, up 25.75% year-over-year.
Net profit attributable to shareholders: ¥537 million, up 26.38% year-over-year.
Operating cash flow: ¥549 million, up 23.53% year-over-year.
Basic and diluted EPS: ¥3.82, up over 26% year-over-year.
Gross margin: 73.0% (calculated from disclosed cost and revenue).
Outlook and guidance
The company expects continued growth driven by product innovation, market expansion, and increased penetration in both domestic and international markets.
Ongoing investments in R&D and manufacturing capacity are expected to support future product launches and market share gains.
- Net profit rose 33% on 27% revenue growth, with strong R&D and market expansion.688617
Q2 2024 - Revenue and net profit surged over 25% year-over-year, with strong R&D and global expansion.688617
Q4 2024 - Q3 revenue and net profit rose over 20% year-over-year, with strong adjusted profit growth.688617
Q3 2024 - H1 2025 revenue and profit surged over 20% year-over-year, with robust growth across all segments.688617
Q2 2025 - Q1 2025 revenue and net profit surged over 20% year-over-year, with robust cash flow growth.688617
Q1 2025 - 2025 revenue up 25.08% and net profit up 21.91%, with strong R&D and global expansion.688617
Q4 2025 - Revenue up 22.47% and net profit up 18.02% year-over-year, with strong cash flow and R&D growth.688617
Q3 2025 - Revenue and net profit surged over 24% year-over-year, with EPS up 26.15% in Q1 2026.688617
Q1 2026
Next APT Medical earnings date
Next APT Medical earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage